|
1
|
Dhingra N and Bhagwat D: Benign prostatic
hyperplasia: An overview of existing treatment. Indian J Pharmacol.
43:6–12. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roehrborn CG and McConnell J: Benign
prostatic hyperplasia: Etiology, pathophysiology, epidemiology and
natural historyCampbell's Urology. Walsh PC, Retik AB, Vaughan ED
Jr and Wein AJ: 8th edition. WB Saunders Co; Philadelphia, PA: pp.
1297–1336. 2002
|
|
3
|
Moore A, Butcher MJ and Köhler TS:
Testosterone replacement therapy on the natural history of prostate
disease. Curr Urol Rep. 16:512015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Silva IS, Morsch DM, Urnauer L and
Spritzer PM: Androgen-induced cell growth and c-myc expression in
human non-transformed epithelial prostatic cells in primary
culture. Endocr Res. 27:153–169. 2009. View Article : Google Scholar
|
|
5
|
Furuya Y and Isaacs JT: Differential gene
regulation during programmed death (apoptosis) versus proliferation
of prostatic glandular cells induced by androgen manipulation.
Endocrinology. 133:2660–2666. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Raffo AJ, Perlman H, Chen MW, Day ML,
Streitman JS and Buttyan R: Overexpression of bcl-2 protects
prostate cancer cells from apoptosis in vitro and confers
resistance to androgen depletion in vivo. Cancer Res. 55:4438–4445.
1995.PubMed/NCBI
|
|
7
|
Roehrborn CG: Benign prostatic
hyperplasia: An overview. Rev Urol. 7 Suppl 9:S3–S14.
2005.PubMed/NCBI
|
|
8
|
Klionsky DJ, Abdelmohsen K, Abe A, Abedin
MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD,
Adeli K, et al: Guidelines for the use and interpretation of assays
for monitoring autophagy (3rd edition). Autophagy. 12:1–222. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fimia GM and Piacentini M: Regulation of
autophagy in mammals and its interplay with apoptosis. Cell Mol
Life Sci. 67:1581–1588. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maiuri MC, Zalckvar E, Kimchi A and
Kroemer G: Self-eating and self-killing: Crosstalk between
autophagy and apoptosis. Nat Rev Mol Cell Biol. 8:741–752. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ravikumar B, Berger Z, Vacher C, O'Kane CJ
and Rubinsztein DC: Rapamycin pre-treatment protects against
apoptosis. Hum Mol Genet. 15:1209–1216. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eisenberg-Lerner A, Bialik S, Simon HU and
Kimchi A: Life and death partners: Apoptosis, autophagy and the
cross-talk between them. Cell Death Differ. 16:966–975. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li M, Jiang X, Liu D, Na Y, Gao GF and Xi
Z: Autophagy protects LNCaP cells under androgen deprivation
conditions. Autophagy. 4:54–60. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li M, Yang X, Wang H, Xu E and Xi Z:
Inhibition of androgen induces autophagy in benign prostate
epithelial cells. Int J Urol. 21:195–199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wirawan E, Vande Walle L, Kersse K,
Cornelis S, Claerhout S, Vanoverberghe I, Roelandt R, De Rycke R,
Verspurten J, Declercq W, et al: Caspase-mediated cleavage of
Beclin-1 inactivates Beclin-1-induced autophagy and enhances
apoptosis by promoting the release of proapoptotic factors from
mitochondria. Cell Death Dis. 1:e182010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Djavaheri-Mergny M, Maiuri MC and Kroemer
G: Cross talk between apoptosis and autophagy by caspase-mediated
cleavage of Beclin 1. Oncogene. 29:1717–1719. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hayward SW, Dahiya R, Cunha GR, Bartek J,
Deshpande N and Narayan P: Establishment and characterization of an
immortalized but non-transformed human prostate epithelial cell
line: BPH-1. In Vitro Cell Dev Biol Anim. 31:14–24. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sedelaar JP and Isaacs JT: Tissue culture
media supplemented with 10% fetal calf serum contains a castrate
level of testosterone. Prostate. 69:1724–1729. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kabeya Y, Mizushima N, Ueno T, Yamamoto A,
Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a
mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Klionsky DJ, Abdalla FC, Abeliovich H,
Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M,
Agostinis P, Aguirre-Ghiso JA, et al: Guidelines for the use and
interpretation of assays for monitoring autophagy. Autophagy.
8:445–544. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Altman BJ, Wofford JA, Zhao Y, Coloff JL,
Ferguson EC, Wieman HL, Day AE, Ilkayeva O and Rathmell JC:
Autophagy provides nutrients but can lead to chop-dependent
induction of bim to sensitize growth factor-deprived cells to
apoptosis. Mol Biol Cell. 20:1180–1191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Isaacs JT: Antagonistic effect of androgen
on prostatic cell death. Prostate. 5:545–557. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He C and Klionsky DJ: Regulation
mechanisms and signaling pathways of autophagy. Annu Rev Genet.
43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nickel JC, Gilling P, Tammela TL, Morrill
B, Wilson TH and Rittmaster RS: Comparison of dutasteride and
finasteride for treating benign prostatic hyperplasia: The Enlarged
Prostate International Comparator Study (EPICS). BJU Int.
108:388–394. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McVary KT, Roehrborn CG, Avins AL, Barry
MJ, Bruskewitz RC, Donnell RF, Foster HE Jr, Gonzalez CM, Kaplan
SA, Penson DF, et al: Update on AUA guideline on the management of
benign prostatic hyperplasia. J Urol. 185:1793–1803. 2011.
View Article : Google Scholar : PubMed/NCBI
|
